Dietary alpha-ketoglutarate inhibits SARS CoV-2 infection and rescues inflamed lungs to restore O
2
saturation by inhibiting pAkt
Clin Transl Med
.
2022 Sep;12(9):e1041.
doi: 10.1002/ctm2.1041.
Authors
Sakshi Agarwal
1
,
Simrandeep Kaur
1
,
Tejeswara Rao Asuru
1
,
Garima Joshi
1
,
Nishith M Shrimali
1
,
Anamika Singh
1
,
Oinam Ningthemmani Singh
2
,
Puneet Srivastva
2
,
Tripti Shrivastava
2
,
Sudhanshu Vrati
1
,
Milan Surjit
2
,
Prasenjit Guchhait
1
Affiliations
1
Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India.
2
Translational Health Science Technology Institute, National Capital Region Biotech Science Cluster, Faridabad, India.
PMID:
36121179
PMCID:
PMC9484267
DOI:
10.1002/ctm2.1041
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
Ketoglutaric Acids / pharmacology
Lung
Severe Acute Respiratory Syndrome*
Virus Replication
Substances
Ketoglutaric Acids